Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Maryland guideMaryland Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Maryland
  4. ›Healthcare and Medical Services
  5. ›Lung, Prostate, Colorectal, and Breast Cancers Creative…

Maryland Department of Health & Mental Hygiene·Maryland

Lung, Prostate, Colorectal, and Breast Cancers Creative Design RFP

Closes 11/12/2025$200k – $500kRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Maryland Department of Health is seeking a qualified vendor to assist in the development and implementation of a comprehensive public education campaign targeting communities disproportionately impacted by lung, prostate, colorectal, and breast cancers. The campaign aims to provide educational information on cancer risks and warning signs, promote screenings, and inform the public about legislation that reduces cost barriers to prevention services. The vendor will be responsible for conducting listening sessions with communities, developing a plan for placement, creating culturally relevant and persuasive communication materials, and utilizing focus groups and stakeholder input to inform the materials developed. • The vendor must have at least five years of experience in graphic design and advertising campaigns for the public and/or healthcare professionals. • The vendor must provide proof of meeting the minimum qualifications, including letters of recommendation from three current clients. • The vendor must comply with the Americans with Disabilities Act and ensure that all materials developed are accessible to persons with disabilities. • The vendor must provide a comprehensive work plan outlining the specific timeline of the development of video, digital, radio, and print assets.

Attached files

Contact

Augustus Woyah(Procurement Officer)

[email protected]

(410) 767-5039

Key dates

Opened
10/22/2025
Questions due
11/5/2025
Closes
11/12/2025
Duration
6 months

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541810
Solicitation №
BPM053749

Budget estimate

$200,000 – $500,000

The budget for this opportunity is estimated to be around $200,000 to $500,000, based on the scope of work and the requirements of the project. The vendor will be responsible for developing a comprehensive public education campaign, which includes advertising, marketing, and graphic design services. The estimated budget range is based on industry standards for similar projects and the level of expertise required to complete the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

Top match · 69%

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Closes 11/18/2026Opened 8/20/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

68% match

DoW Rare Cancers Idea Development Award

Closes 11/18/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

University of Texas MD Anderson Cancer Center·Texas

68% match

Discovery and Development of Small Molecules and Biologic Therapies RFP

Closes 12/9/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

68% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. Centers for Disease Control - NCCDPHP·United States of America

67% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

67% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Food and Drug Administration·United States of America

67% match

Novel approaches to support therapeutic development in ultra-rare cancers

Rolling / TBD closeOpened 8/4/2025

U.S. Centers for Disease Control - NCCDPHP·United States of America

67% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 3/6/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

66% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

66% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

Maryland Department of Health·Maryland

66% match

PHPA 4166: Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program

Closes 11/20/2026Opened 9/21/2026

Mississippi Department of Health·Mississippi

66% match

Cancer Survivorship Evaluation

Closes 11/2/2026Opened 10/13/2026

U.S. National Institutes of Health·United States of America

66% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

66% match

DoW Breast Cancer, Clinical Research Extension Award

Closes 11/18/2026Opened 8/20/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

66% match

DoW Peer Reviewed Cancer, Clinical Trial Award

Rolling / TBD closeOpened 5/6/2026

U.S. National Institutes of Health·United States of America

66% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

66% match

Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support Tools

Closes 4/21/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

66% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

65% match

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

65% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. National Institutes of Health·United States of America

65% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025